Part 2: Importance and Implications of Biomarkers in Diagnosis and Modern Treatment of Alzheimer’s Disease |
|
Enduring |
|
$0.00 |
Decoding CIDP Strategies to Overcome Common Diagnostic and Therapeutic Pitfalls |
|
Enduring |
|
$0.00 |
Networks in Neurology: Insights From a Collaborative CME Experience With Practicing Clinicians Regarding New Agents and Strategies for Multiple... |
|
Enduring |
|
$0.00 |
Part 3: Evolving Roles in Alzheimer’s Disease Management: Team-Based Care in the Modern Age of Disease-Modifying Therapy |
|
Enduring |
|
$0.00 |
Reshaping the Paradigm: Implications of Recent Clinical Advances in the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) --... |
|
Enduring |
|
$0.00 |
Alzheimer’s Disease Diagnosis Time Outs: A Deep Dive into Challenging Clinical Scenarios for Early Alzheimer's Diagnosis and Treatment |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance
|
Enduring |
|
$0.00 |
Why Now? The New Paradigm and Rising Role of Nuclear Medicine in Alzheimer’s Disease (Credit Expired) |
|
Enduring |
|
$0.00 |
Overburdened, Undertreated: Developments in the Patient-Centered Management of Spasticity in Multiple Sclerosis |
|
Enduring |
|
$0.00 |
How Do I…? An Integrated CME Activity Designed to Assess and Compare the Clinical Decisions of Multiple Sclerosis Specialists and General... |
|
Enduring |
|
$0.00 |
The ARIA Toolkit: An Interdisciplinary Curriculum to Optimize Team-Based Management of Amyloid-Related Imaging Abnormalities in Alzheimer’s Disease |
|
Enduring |
|
$0.00 |
Over-Impacted, Under-Represented: Addressing Health Disparities in Multiple Sclerosis |
|
Enduring |
|
$0.00 |
Across the Spectrum: Transforming the Detection and Management of Disease State Transitions Across the Spectrum of Multiple Sclerosis (Credit Expired) |
|
Enduring |
|
$0.00 |
Module 1: Diagnosis and Progression Monitoring |
|
Enduring |
|
$0.00 |
Different Strokes: Addressing Real Clinician Questions and Controversies Surrounding Acute Management of Ischemic Stroke (Credit Expired) |
|
Enduring |
|
$0.00 |
Inside Myasthenia Gravis: Where Providers and Patients Diverge on Defining Treatment Success |
|
Enduring |
|
$0.00 |